Table 2:

Patient outcomes. Data are n (%) and mean (SD). EQ-5D= EuroQol Group 5-Dimension.

Outcome	Placebo n=30	IV glyburide n=35	Effect size (95% CI)	p-value
Mortality (%)
90 days	10 (33%)	4 (11%)
6 months	11 (37%)	5 (14%)
12 months	12 (40%)	5 (14%)	HR 0.34 (0.12 – 0.96)	0.042*
Barthel Index mean (SD)
90 days	34.5 (36.5)	50.7 (36.4)
6 months	39.5 (39.3)	54.4 (37.3)
12 months	39.5 (40.1)	60.1(37.9)	20 (2.1 – 37)	0.029†
EQ-5D mean (SD)
90 days	0.29 (0.30)	0.43 (0.32)
6 months	0.33 (0.34)	0.49 (0.32)
12 months	0.33 (0.32)	0.49 (0.31)	0.154 (0.001 – 0.249)	0.048†

^*denotes p-value is from a log-rank test;

^†p-value is from a linear, repeated measures GEE model for longitudinal outcomes.